
    
      This study will be run in 2 parts. The first part involves applying escalating concentrations
      of the new vehicle formulations containing ingenol mebutate to AKs on the forearms. Reactions
      and safety will be compared to Picato® (a registered and marketed ingenol mebutate gel) to
      ascertain if the new vehicle formulations are at least as safe and effective as Picato® . The
      purpose of part 2 is to select the concentration in the "new formulation" that produces this
      same, if not better response, as Picato® and with a similar or better safety profile.
    
  